Sylva H. Collins

Statistics

Publications

Citations

530

H-Index

Active since

1984

Affiliations

Cubist Pharmaceuticals (United States)(Current)

Sylva H. Collins is an author at Cubist Pharmaceuticals (United States) specializing in pharmacy, infectious diseases, and empiric antimicrobial therapy.

Publications per year

1984–2025

Publications

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)

Joseph S. Solomkin, Ellie Hershberger, Benjamin Miller et al. · Clinical Infectious Diseases · 2015 · 410 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors

Ralph B. D’Agostino, Sylva H. Collins, Karol M. Pencina et al. · Clinical Infectious Diseases · 2014 · 87 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Determination of flumequine and a hydroxy metabolite in biological fluids by high-pressure liquid chromatographic, fluorometric, and microbiological methods

Lester I. Harrison, D Schuppan, S R Rohlfing et al. · Antimicrobial Agents and Chemotherapy · 1984 · 23 citations

Medicine, Pharmaceutical Analysis, Pharmacology +14

A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events

Thomas R. Fleming, Kevin J. Carroll, Janet Wittes et al. · Statistics in Medicine · 2025 · 10 citations · Full text

Public Health, Biostatistics, Causal Inference +15

1–4 of 4